Acute Bell's palsy Nervous System Diseases Bell palsy
Conditions
Interventions
In the present study, the researchers are recruiting a small number of patients to be able to obtain an estimate of the effectiveness of the new therapy called “Mirror Effect”. The Mirror Effect thera
Sponsors
Centres Intégré Universitaires de Santé et de Services Sociaux
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged 18 years and older 2. First episode of Bell's Palsy 3. Having persistent severe Bell's palsy 10 days post-onset 4. Received the recommended drug regimen for severe and total BP (1000 mg valacyclovir three times daily for 7 days and 50 mg prednisone once daily for 10 days) began within 72 hours of onset 5. Normal cognitive status based on the Montreal Cognitive Assessment
Exclusion criteria
Exclusion criteria: 1. History of trauma to the 7th cranial nerve 2. Having suffered from Bell's palsy previously or any other facial palsy of another origin (e.g. secondary to surgery or a syndrome 3. History of neurological disorders (e.g. stroke, neurodegenerative diseases) 4. Psychiatric illness on active treatment (e.g. schizophrenia, severe depression) 5. History of neoplastic diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of facial palsy assessed using the Facial Nerve Grading System 2.0 (FNGS 2.0; also known as the House-Brackmann 2.0 score and the Sunnybrook Facial Grading System at the initial assessment (10 to 14 days after onset) as well as 1, 2, 3, 4, 5, 6 and 12 months after onset | — |
Secondary
| Measure | Time frame |
|---|---|
| Speech intelligibility measured using a visual analog scale at the initial assessment (10 to 14 days after onset) as well as 1, 2, 3, 4, 5, 6 and 12 months after onset | — |
Countries
Canada
Contacts
Public ContactSarah Martineau
Outcome results
None listed